Protocol Modification of Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome Study

Clin Appl Thromb Hemost. 2018 Jan;24(1):192. doi: 10.1177/1076029617729214. Epub 2017 Sep 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Antiphospholipid
  • Antiphospholipid Syndrome*
  • Humans
  • Pyrazoles
  • Pyridones
  • Secondary Prevention*
  • Thrombosis

Substances

  • Antibodies, Antiphospholipid
  • Pyrazoles
  • Pyridones
  • apixaban